Korean J Thorac Cardiovasc Surg.
2006 Aug;39(8):604-610.
Early and Midterm Results of Coronary Artery Bypass Grafting in Patients with Ischemic Cardiomyopathy (LVEF
- Affiliations
-
- 1Department of Thoracic and Cardiovascular Surgery, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Korea.
- 2Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea. kiick.sung@samsung.com
- 3Department of Thoracic and Cardiovascular Surgery, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Korea.
- 4Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Korea.
Abstract
-
BACKGROUND: Recent improvements in interventional procedure and medical therapy for congestive heart failure result in an increase of number of patients with ischemic cardiomyopathy considered for coronary artery bypass grafting. We retrospectively review the results of CABG in these patients with decreased LV function to know the early and mid-term follow-up results.
MATERIAL AND METHOD: Between January 2001 and June 2005, 1,143 patients underwent coronary artery bypass grafting and 144 of these patients had preoperative left ventricular function of equal to or less than 35% (LVEF < or =35%). There were off-pump coronary artery bypass grafting (OPCAB) in 66 cases (45.8%), on-pump beating heart coronary artery bypass grafting in 34 cases (23.6%) and conventional coronary artery bypass grafting in 44 cases (30.6%). The combined operations including mitral annuloplasty were 48 cases in thirty five patients (24.3%).
RESULT: The mean number of dstal anastomosis were 3.5+/-1.3. The median postoperative duration of stay in intensive care unit and hospital was 2 days and 8 days, respectively. There were 6 early death (4.2%) and causes of deaths were ventricular tachycardia in 5 patients, small bowel infarction in one patient. Mean follow-up time was 21+/-14 months (4~54 months). The 1-year was 95+/-2% and 3-year survival rate was 83+/-7%, the 1-year and 3-year cardiac event-free survival were 88+/-3% and 69+/-7%, respectively.
CONCLUSION
Based on satisfactory early and mid-term results in our study, CABG should be carried out as actively as possible in patients with ischemic cardiomyopathy. Postoperative aggressive management for ventricular arrhythmia would be helpful for better results.